Tapewire

Nasdaq · USD

RARE

Ultragenyx Pharmaceutical Inc.

Export transactions ↓
Tapewire entity
4337
SEC CIK
0001515673
Parsed reports
478

Last 12 months

Inside the activity.

0 purchase rows · 27 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202502
Jan 202601
Feb 202601
Mar 2026011
Apr 202601
May 202603
Jun 202603
Jul 202601
Aug 202602
Sep 202602
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
March 01, 2023 Filed Mar 4, 2023 00:52 UTC
KAKKIS EMIL DDirector · President & CEO
GrantCommon Stock 46,200 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-016041 · doc4.xml · nonDerivative · entry 2

KAKKIS EMIL D · CIK 0001248093 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 615,606

F2 · shares: Award of Restricted Stock Units ("RSUs") under the Company's 2014 Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date.

Read SEC document
March 01, 2023 Filed Mar 4, 2023 00:52 UTC
KAKKIS EMIL DDirector · President & CEO
GrantCommon Stock 8,716 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-016041 · doc4.xml · nonDerivative · entry 1

KAKKIS EMIL D · CIK 0001248093 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 569,406

F1 · shares: Represents shares of common stock which previously granted performance stock units were converted on March 1, 2023 upon certification of the performance metric.

Read SEC document
March 01, 2023 Filed Mar 4, 2023 01:00 UTC
Bedrosian Camille LEVP and Chief Medical Officer
SaleCommon Stock 3,881 $45.25 $175,615.25
Disclosure

SEC source: 0001209191-23-016053 · doc4.xml · nonDerivative · entry 2

Bedrosian Camille L · CIK 0001326969 · EVP and Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,720

F2 · shares: Represents shares sold to pay required tax withholdings due to the vesting of Restricted Stock Units ("RSUs").

F3 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.

Read SEC document
March 01, 2023 Filed Mar 4, 2023 01:00 UTC
Bedrosian Camille LEVP and Chief Medical Officer
GrantCommon Stock 2,663 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-016053 · doc4.xml · nonDerivative · entry 1

Bedrosian Camille L · CIK 0001326969 · EVP and Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,601

F1 · shares: Represents shares of common stock into which previously granted performance stock units were converted on March 1, 2023 upon certification of the performance metric.

Read SEC document
March 01, 2023 Filed Mar 4, 2023 00:59 UTC
Parschauer Karah HerdmanEVP and Chief Legal Officer
GrantStock Option (Right to Buy) · Derivative 39,400 $0.00 Strike: $45.65 $0.00
Disclosure

SEC source: 0001209191-23-016047 · doc4.xml · derivative · entry 4

Parschauer Karah Herdman · CIK 0001677455 · EVP and Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,400

Underlying: Common Stock · 39,400 shares

Expires 2033-03-01

F6 · derivative.exercise_date: On the first anniversary of the grant date of the option (the "Option Anniversary Date"), 1/4th of the shares initially subject to the option shall vest; thereafter, 1/48th of the shares initially subject to the option shall vest on each month as measured from the Option Anniversary Date.

Read SEC document
March 01, 2023 Filed Mar 4, 2023 00:59 UTC
Parschauer Karah HerdmanEVP and Chief Legal Officer
SaleCommon Stock 3,161 $45.25 $143,035.25
Disclosure

SEC source: 0001209191-23-016047 · doc4.xml · nonDerivative · entry 3

Parschauer Karah Herdman · CIK 0001677455 · EVP and Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,139

F3 · shares: Represents shares sold to pay required tax withholdings due to the vesting of RSUs.

F4 · balance_after: Includes 199 shares acquired under the Company's 2014 Employee Stock Purchase Plan on October 31, 2022.

F5 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.

Read SEC document
March 01, 2023 Filed Mar 4, 2023 00:59 UTC
Parschauer Karah HerdmanEVP and Chief Legal Officer
GrantCommon Stock 22,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-016047 · doc4.xml · nonDerivative · entry 2

Parschauer Karah Herdman · CIK 0001677455 · EVP and Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,101

F2 · shares: Award of Restricted Stock Units ("RSUs") under the Company's 2014 Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date.

Read SEC document
March 01, 2023 Filed Mar 4, 2023 00:59 UTC
Parschauer Karah HerdmanEVP and Chief Legal Officer
GrantCommon Stock 2,663 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-016047 · doc4.xml · nonDerivative · entry 1

Parschauer Karah Herdman · CIK 0001677455 · EVP and Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,101

F1 · shares: Represents shares of common stock which previously granted performance stock units were converted on March 1, 2023 upon certification of the performance metric.

Read SEC document
March 01, 2023 Filed Mar 4, 2023 00:54 UTC
Huizenga Theodore AlanSVP, Chief Accounting Officer
GrantStock Option (Right to Buy) · Derivative 10,120 $0.00 Strike: $45.65 $0.00
Disclosure

SEC source: 0001209191-23-016045 · doc4.xml · derivative · entry 4

Huizenga Theodore Alan · CIK 0001603347 · SVP, Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,120

Underlying: Common Stock · 10,120 shares

Expires 2033-03-01

F5 · derivative.exercise_date: On the first anniversary of the grant date of the option (the "Option Anniversary Date"), 1/4th of the shares initially subject to the option shall vest; thereafter, 1/48th of the shares initially subject to the option shall vest on each month as measured from the Option Anniversary Date.

Read SEC document
March 01, 2023 Filed Mar 4, 2023 00:54 UTC
Huizenga Theodore AlanSVP, Chief Accounting Officer
Disposition to issuerCommon Stock 1,333 $45.65 $60,851.45
Disclosure

SEC source: 0001209191-23-016045 · doc4.xml · nonDerivative · entry 3

Huizenga Theodore Alan · CIK 0001603347 · SVP, Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,715

F3 · shares: Shares were acquired upon the partial vesting of a previously reported RSU and were sold to permit the cash value of the awards to be credited to the deferred compensation plan account of the Reporting Person.

F4 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.

Read SEC document
March 01, 2023 Filed Mar 4, 2023 00:54 UTC
Huizenga Theodore AlanSVP, Chief Accounting Officer
SaleCommon Stock 100 $45.65 $4,565.00
Disclosure

SEC source: 0001209191-23-016045 · doc4.xml · nonDerivative · entry 2

Huizenga Theodore Alan · CIK 0001603347 · SVP, Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,048

F2 · shares: Represents shares sold to pay required tax withholdings due to the vesting of RSUs.

Read SEC document
March 01, 2023 Filed Mar 4, 2023 00:54 UTC
Huizenga Theodore AlanSVP, Chief Accounting Officer
GrantCommon Stock 7,590 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-016045 · doc4.xml · nonDerivative · entry 1

Huizenga Theodore Alan · CIK 0001603347 · SVP, Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,148

F1 · shares: Award of Restricted Stock Units ("RSUs") under the Company's 2014 Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date.

Read SEC document
March 01, 2023 Filed Mar 4, 2023 00:53 UTC GrantStock Option (Right to Buy) · Derivative 39,400 $0.00 Strike: $45.65 $0.00
Disclosure

SEC source: 0001209191-23-016043 · doc4.xml · derivative · entry 5

Huang Dennis Karl · CIK 0001641217 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,400

Underlying: Common Stock · 39,400 shares

Expires 2033-03-01

F6 · derivative.exercise_date: On the first anniversary of the grant date of the option (the "Option Anniversary Date"), 1/4th of the shares initially subject to the option shall vest; thereafter, 1/48th of the shares initially subject to the option shall vest on each month as measured from the Option Anniversary Date.

Read SEC document
March 01, 2023 Filed Mar 4, 2023 00:53 UTC Disposition to issuerCommon Stock 10,599 $45.65 $483,844.35
Disclosure

SEC source: 0001209191-23-016043 · doc4.xml · nonDerivative · entry 4

Huang Dennis Karl · CIK 0001641217 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 64,715

F4 · shares: Shares were acquired upon the partial vesting of a previously reported RSU and were sold to permit the cash value of the awards to be credited to the deferred compensation plan account of the Reporting Person.

F5 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.

Read SEC document
March 01, 2023 Filed Mar 4, 2023 00:53 UTC SaleCommon Stock 389 $45.65 $17,757.85
Disclosure

SEC source: 0001209191-23-016043 · doc4.xml · nonDerivative · entry 3

Huang Dennis Karl · CIK 0001641217 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,314

F3 · shares: Represents shares sold to pay required tax withholdings due to the vesting of RSUs.

Read SEC document
March 01, 2023 Filed Mar 4, 2023 00:53 UTC GrantCommon Stock 22,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-016043 · doc4.xml · nonDerivative · entry 2

Huang Dennis Karl · CIK 0001641217 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,703

F2 · shares: Award of Restricted Stock Units ("RSUs") under the Company's 2014 Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date.

Read SEC document
March 01, 2023 Filed Mar 4, 2023 00:53 UTC GrantCommon Stock 2,663 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-016043 · doc4.xml · nonDerivative · entry 1

Huang Dennis Karl · CIK 0001641217 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,703

F1 · shares: Represents shares of common stock which previously granted performance stock units were converted on March 1, 2023 upon certification of the performance metric.

Read SEC document
March 01, 2023 Filed Mar 4, 2023 00:53 UTC Grant3/1/2023 · Derivative 39,400 $0.00 Strike: $45.65 $0.00
Disclosure

SEC source: 0001209191-23-016042 · doc4.xml · derivative · entry 5

Pinion John Richard · CIK 0001648096 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,400

Underlying: Common Stock · 39,400 shares

Expires 2033-03-01

F6 · derivative.exercise_date: On the first anniversary of the grant date of the option (the "Option Anniversary Date"), 1/4th of the shares initially subject to the option shall vest; thereafter, 1/48th of the shares initially subject to the option shall vest on each month as measured from the Option Anniversary Date.

Read SEC document
March 01, 2023 Filed Mar 4, 2023 00:53 UTC Disposition to issuerCommon Stock 4,014 $45.65 $183,239.10
Disclosure

SEC source: 0001209191-23-016042 · doc4.xml · nonDerivative · entry 4

Pinion John Richard · CIK 0001648096 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 76,160

F4 · shares: Shares were acquired upon the partial vesting of a previously reported RSU and were sold to permit the cash value of the awards to be credited to the deferred compensation plan account of the Reporting Person

F5 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.

Read SEC document
March 01, 2023 Filed Mar 4, 2023 00:53 UTC SaleCommon Stock 3,755 $45.26 $169,951.30
Disclosure

SEC source: 0001209191-23-016042 · doc4.xml · nonDerivative · entry 3

Pinion John Richard · CIK 0001648096 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 80,174

F3 · shares: Represents shares sold to pay required tax withholdings due to the vesting of RSUs.

Read SEC document
March 01, 2023 Filed Mar 4, 2023 00:53 UTC GrantCommon Stock 22,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-016042 · doc4.xml · nonDerivative · entry 2

Pinion John Richard · CIK 0001648096 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 83,929

F2 · shares: Award of Restricted Stock Units ("RSUs") under the Company's 2014 Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date.

Read SEC document
March 01, 2023 Filed Mar 4, 2023 00:53 UTC GrantCommon Stock 2,663 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-016042 · doc4.xml · nonDerivative · entry 1

Pinion John Richard · CIK 0001648096 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 61,929

F1 · shares: Represents shares of common stock which previously granted performance stock units were converted on March 1, 2023 upon certification of the performance metric.

Read SEC document
March 01, 2023 Filed Mar 4, 2023 00:51 UTC
Harris ErikEVP & Chief Commercial Officer
GrantStock Option (Right to Buy) · Derivative 39,400 $0.00 Strike: $45.65 $0.00
Disclosure

SEC source: 0001209191-23-016039 · doc4.xml · derivative · entry 4

Harris Erik · CIK 0001780113 · EVP & Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,400

Underlying: Common Stock · 39,400 shares

Expires 2033-03-01

F6 · derivative.exercise_date: On the first anniversary of the grant date of the option (the "Option Anniversary Date"), 1/4th of the shares initially subject to the option shall vest; thereafter, 1/48th of the shares initially subject to the option shall vest on each month as measured from the Option Anniversary Date.

Read SEC document
March 01, 2023 Filed Mar 4, 2023 00:51 UTC
Harris ErikEVP & Chief Commercial Officer
SaleCommon Stock 3,664 $45.25 $165,796.00
Disclosure

SEC source: 0001209191-23-016039 · doc4.xml · nonDerivative · entry 3

Harris Erik · CIK 0001780113 · EVP & Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 57,344

F3 · shares: Represents shares sold to pay required tax withholdings due to the vesting of RSUs.

F4 · balance_after: Includes 185 shares acquired under the Company's 2014 Employee Stock Purchase Plan on October 31, 2022

F5 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.

Read SEC document
March 01, 2023 Filed Mar 4, 2023 00:51 UTC
Harris ErikEVP & Chief Commercial Officer
GrantCommon Stock 22,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-016039 · doc4.xml · nonDerivative · entry 2

Harris Erik · CIK 0001780113 · EVP & Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,823

F2 · shares: Award of Restricted Stock Units ("RSUs") under the Company's 2014 Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date.

Read SEC document
March 01, 2023 Filed Mar 4, 2023 00:51 UTC
Harris ErikEVP & Chief Commercial Officer
GrantCommon Stock 2,663 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-016039 · doc4.xml · nonDerivative · entry 1

Harris Erik · CIK 0001780113 · EVP & Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,823

F1 · shares: Represents shares of common stock which previously granted performance stock units were converted on March 1, 2023 upon certification of the performance metric.

Read SEC document
February 28, 2023 Filed Mar 2, 2023 19:28 UTC
Huizenga Theodore AlanSVP, Chief Accounting Officer
SaleCommon Stock 639 $43.40 $27,732.60
Disclosure

SEC source: 0001209191-23-014502 · doc4.xml · nonDerivative · entry 1

Huizenga Theodore Alan · CIK 0001603347 · SVP, Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,558

F1 · kind: The transaction reported on this Form 4 was effected pursuant to a trading plan adopted by the Reporting Person pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.

F2 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.

Read SEC document
December 30, 2022 Filed Jan 3, 2023 21:45 UTC
KAKKIS EMIL DDirector · President & CEO
SaleCommon Stock 19,582 $45.57 $892,351.74
Disclosure

SEC source: 0001209191-23-000276 · doc4.xml · nonDerivative · entry 1

KAKKIS EMIL D · CIK 0001248093 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 541,108

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a trading plan adopted by the Reporting Person pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.94 to $46.36 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F3 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.

Read SEC document
December 21, 2022 Filed Dec 22, 2022 18:24 UTC
Huizenga Theodore AlanSVP, Chief Accounting Officer
SaleCommon Stock 2,031 $43.96 $89,282.76
Disclosure

SEC source: 0001209191-22-062400 · doc4.xml · nonDerivative · entry 1

Huizenga Theodore Alan · CIK 0001603347 · SVP, Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,197

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a trading plan adopted by the Reporting Person pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.

F2 · balance_after: Includes 134 shares acquired under the Company's 2014 Employee Stock Purchase Plan on October 31, 2022

F3 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.

Read SEC document
October 14, 2022 Filed Oct 17, 2022 22:49 UTC
Dier MardiCFO & Executive Vice President
SaleCommon Stock 1,629 $40.16 $65,420.64
Disclosure

SEC source: 0001209191-22-053884 · doc4.xml · nonDerivative · entry 1

Dier Mardi · CIK 0001574591 · CFO & Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,695

F1 · kind: The sales reported on this Form 4 were effected pursuant to a trading plan adopted by the Reporting Person pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.

F2 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.

Read SEC document
October 12, 2022 Filed Oct 14, 2022 16:58 UTC
Dier MardiCFO & Executive Vice President
SaleCommon Stock 3,484 $38.22 $133,158.48
Disclosure

SEC source: 0001209191-22-053647 · doc4.xml · nonDerivative · entry 1

Dier Mardi · CIK 0001574591 · CFO & Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 68,324

F1 · kind: Represents shares sold to pay required tax withholdings due to the vesting of Restricted Stock Units ("RSUs").

F2 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.

Read SEC document
September 16, 2022 Filed Sep 20, 2022 01:39 UTC
Dier MardiCFO & Executive Vice President
GrantCommon Stock 20,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-050670 · doc4.xml · nonDerivative · entry 1

Dier Mardi · CIK 0001574591 · CFO & Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 71,808

F1 · shares: Award of Restricted Stock Units ("RSUs") under the Company's 2014 Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date.

F2 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.

Read SEC document
September 01, 2022 Filed Sep 8, 2022 22:36 UTC
Huizenga Theodore AlanSVP, Chief Accounting Officer
GrantCommon Stock 1,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-049222 · doc4.xml · nonDerivative · entry 1

Huizenga Theodore Alan · CIK 0001603347 · SVP, Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,094

F1 · shares: Award of Restricted Stock Units ("RSUs") under the Company's 2014 Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date.

F2 · balance_after: Includes 180 shares acquired under the Company's 2014 Employee Stock Purchase Plan on April 30, 2022.

F3 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.

Read SEC document
June 24, 2022 Filed Jun 28, 2022 13:50 UTC
Ray AmritDirector
GrantStock Option (Right to Buy) · Derivative 6,245 $0.00 Strike: $60.57 $0.00
Disclosure

SEC source: 0001209191-22-039564 · doc4.xml · derivative · entry 2

Ray Amrit · CIK 0001924797 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,245

Underlying: Common Stock · 6,245 shares

Expires 2032-06-24

F2 · derivative.exercise_date: The option shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 24, 2023.

Read SEC document
June 24, 2022 Filed Jun 28, 2022 13:50 UTC
Ray AmritDirector
GrantCommon Stock 3,300 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-039564 · doc4.xml · nonDerivative · entry 1

Ray Amrit · CIK 0001924797 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,420

F1 · shares: Award of Restricted Stock Units ("RSUs") under the Company's 2014 Incentive Plan. The RSUs shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 24, 2023.

Read SEC document
June 24, 2022 Filed Jun 28, 2022 17:54 UTC GrantStock Option (Right to Buy) · Derivative 6,245 $0.00 Strike: $60.57 $0.00
Disclosure

SEC source: 0001209191-22-039568 · doc4.xml · derivative · entry 2

WELCH DANIEL G · CIK 0001206199 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,245

Underlying: Common Stock · 6,245 shares

Expires 2032-06-24

F2 · derivative.exercise_date: The option shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 24, 2023.

Read SEC document
June 24, 2022 Filed Jun 28, 2022 17:54 UTC GrantCommon Stock 3,300 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-039568 · doc4.xml · nonDerivative · entry 1

WELCH DANIEL G · CIK 0001206199 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,745

F1 · shares: Award of Restricted Stock Units ("RSUs") under the Company's 2014 Incentive Plan. The RSUs shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 24, 2023.

Read SEC document
June 24, 2022 Filed Jun 28, 2022 17:48 UTC GrantStock Option (Right to Buy) · Derivative 6,245 $0.00 Strike: $60.57 $0.00
Disclosure

SEC source: 0001209191-22-039561 · doc4.xml · derivative · entry 2

Dunsire Deborah · CIK 0001332764 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,245

Underlying: Common Stock · 6,245 shares

Expires 2032-06-24

F2 · derivative.exercise_date: The option shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 24, 2023.

Read SEC document
June 24, 2022 Filed Jun 28, 2022 17:48 UTC GrantCommon Stock 3,300 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-039561 · doc4.xml · nonDerivative · entry 1

Dunsire Deborah · CIK 0001332764 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,870

F1 · shares: Award of Restricted Stock Units ("RSUs") under the Company's 2014 Incentive Plan. The RSUs shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 24, 2023.

Read SEC document
June 24, 2022 Filed Jun 28, 2022 17:53 UTC
Ekman LarsDirector
GrantStock Option (Right to Buy) · Derivative 6,245 $0.00 Strike: $60.57 $0.00
Disclosure

SEC source: 0001209191-22-039567 · doc4.xml · derivative · entry 2

Ekman Lars · CIK 0001376117 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,245

Underlying: Common Stock · 6,245 shares

Expires 2032-06-24

F2 · derivative.exercise_date: The option shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 24, 2023.

Read SEC document
June 24, 2022 Filed Jun 28, 2022 17:53 UTC
Ekman LarsDirector
GrantCommon Stock 3,300 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-039567 · doc4.xml · nonDerivative · entry 1

Ekman Lars · CIK 0001376117 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,745

F1 · shares: Award of Restricted Stock Units ("RSUs") under the Company's 2014 Incentive Plan. The RSUs shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 24, 2023.

Read SEC document
June 24, 2022 Filed Jun 28, 2022 13:51 UTC GrantStock Option (Right to Buy) · Derivative 6,245 $0.00 Strike: $60.57 $0.00
Disclosure

SEC source: 0001209191-22-039565 · doc4.xml · derivative · entry 2

NARACHI MICHAEL · CIK 0001380022 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,245

Underlying: Common Stock · 6,245 shares

Expires 2032-06-24

F2 · derivative.exercise_date: The option shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 24, 2023.

Read SEC document
June 24, 2022 Filed Jun 28, 2022 13:51 UTC GrantCommon Stock 3,300 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-039565 · doc4.xml · nonDerivative · entry 1

NARACHI MICHAEL · CIK 0001380022 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,745

F1 · shares: Award of Restricted Stock Units ("RSUs") under the Company's 2014 Incentive Plan. The RSUs shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 24, 2023.

Read SEC document
June 24, 2022 Filed Jun 28, 2022 17:52 UTC GrantStock Option (Right to Buy) · Derivative 6,245 $0.00 Strike: $60.57 $0.00
Disclosure

SEC source: 0001209191-22-039566 · doc4.xml · derivative · entry 2

Fust Matthew K · CIK 0001397266 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,245

Underlying: Common Stock · 6,245 shares

Expires 2032-06-24

F2 · derivative.exercise_date: The option shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 24, 2023.

Read SEC document
June 24, 2022 Filed Jun 28, 2022 17:52 UTC GrantCommon Stock 3,300 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-039566 · doc4.xml · nonDerivative · entry 1

Fust Matthew K · CIK 0001397266 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,495

F1 · shares: Award of Restricted Stock Units ("RSUs") under the Company's 2014 Incentive Plan. The RSUs shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 24, 2023.

Read SEC document
June 24, 2022 Filed Jun 28, 2022 17:48 UTC GrantStock Option (Right to Buy) · Derivative 6,245 $0.00 Strike: $60.57 $0.00
Disclosure

SEC source: 0001209191-22-039562 · doc4.xml · derivative · entry 2

SULIMAN SHEHNAAZ · CIK 0001713070 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,245

Underlying: Common Stock · 6,245 shares

Expires 2032-06-24

F2 · derivative.exercise_date: The option shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 24, 2023.

Read SEC document
June 24, 2022 Filed Jun 28, 2022 17:48 UTC GrantCommon Stock 3,300 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-039562 · doc4.xml · nonDerivative · entry 1

SULIMAN SHEHNAAZ · CIK 0001713070 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,995

F1 · shares: Award of Restricted Stock Units ("RSUs") under the Company's 2014 Incentive Plan. The RSUs shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 24, 2023.

Read SEC document
June 24, 2022 Filed Jun 29, 2022 19:48 UTC GrantStock Option (Right to Buy) · Derivative 6,245 $0.00 Strike: $60.57 $0.00
Disclosure

SEC source: 0001209191-22-039770 · doc4.xml · derivative · entry 2

Sanders Corazon (Corsee) D. · CIK 0001796536 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,245

Underlying: Common Stock · 6,245 shares

Expires 2032-06-24

F2 · derivative.exercise_date: The option shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 24, 2023.

Read SEC document
June 24, 2022 Filed Jun 29, 2022 19:48 UTC GrantCommon Stock 3,300 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-039770 · doc4.xml · nonDerivative · entry 1

Sanders Corazon (Corsee) D. · CIK 0001796536 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,195

F1 · shares: Award of Restricted Stock Units ("RSUs") under the Company's 2014 Incentive Plan. The RSUs shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 24, 2023.

Read SEC document
June 19, 2022 Filed Jun 22, 2022 23:27 UTC
Harris ErikEVP & Chief Commercial Officer
SaleCommon Stock 295 $54.78 $16,160.10
Disclosure

SEC source: 0001209191-22-038774 · doc4.xml · nonDerivative · entry 1

Harris Erik · CIK 0001780113 · EVP & Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,160

F1 · kind: Represents shares sold to pay required tax withholdings due to the vesting of Restricted Stock Units ("RSUs").

F2 · balance_after: Includes 138 shares acquired under the Company's 2014 Employee Stock Purchase Plan on April 30, 2022

F3 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.